We found that CD24, which was highly expressed in IBR-CLL patients may be a specific indicator and also a potential target for ibrutinib resistance in CLL (Figure D-G)...The high expression of CD24 is associated with poor prognosis of CLL patients (Figure H)...In sum, our study identifies CD24 as a novel therapeutic target for ibutinib resistance in CLL patients that indicate the prognosis.